Article PDF
References
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300
Hennessy BT, Coleman R, Markman M (2009) Ovarian cancer. Lancet 374:1371–1382
García-Saénz JA, Custodio A, Casado A et al (2011) Platinum-based adjuvant chemotherapy on moderate and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review. Clin Transl Oncol 13:121–132
González-MartÍn A, Toledo G, Chiva L (2010) Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting. Clin Transl Oncol 12:418–430
Vergote I, De Brabanter J, Fyles A et al (2001) Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian cancer. Lancet 357:176–182
Trimbos JB, Parmar M, Vergote I et al (2003) International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant Chemotherapy in Ovarian Neoplasm Trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 95:105–112
Bell J, Brady M, Lage J et al (2003) A randomized phase III trial of three versus six cycles of carboplatin and paclitaxel as adjuvant treatment in early stage ovarian epithelial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol 88:156
Ruiz N, del Campo JM, Calvo E et al (2008) Early stages (I-IIa) epithelial ovarian cancer (EOC): preliminary data of the prospective register of the Spanish Group on Research of Ovarian Cancer (GEICO). Ann Oncol 19[Suppl 8]:viii211–viii216. doi:10.1093/annonc/mdn512
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martín, A.G. Early-stage ovarian cancer management: still a challenge. Clin Transl Oncol 13, 67–68 (2011). https://doi.org/10.1007/s12094-011-0619-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-011-0619-8